- Home
- IPSC vs KOSS Comparison
IPSC vs KOSS Comparison
Compare IPSC & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- KOSS
- Stock Information
- Founded
- IPSC 2019
- KOSS 1953
- Country
- IPSC United States
- KOSS United States
- Employees
- IPSC 165
- KOSS N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- KOSS Consumer Electronics/Appliances
- Sector
- IPSC Health Care
- KOSS Consumer Staples
- Exchange
- IPSC Nasdaq
- KOSS Nasdaq
- Market Cap
- IPSC 49.6M
- KOSS 59.3M
- IPO Year
- IPSC 2021
- KOSS N/A
- Fundamental
- Price
- IPSC $0.58
- KOSS $5.14
- Analyst Decision
- IPSC Strong Buy
- KOSS
- Analyst Count
- IPSC 5
- KOSS 0
- Target Price
- IPSC $3.33
- KOSS N/A
- AVG Volume (30 Days)
- IPSC 868.9K
- KOSS 113.4K
- Earning Date
- IPSC 08-07-2025
- KOSS 05-08-2025
- Dividend Yield
- IPSC N/A
- KOSS N/A
- EPS Growth
- IPSC N/A
- KOSS N/A
- EPS
- IPSC N/A
- KOSS N/A
- Revenue
- IPSC $114,898,000.00
- KOSS $12,433,361.00
- Revenue This Year
- IPSC $1,064.82
- KOSS N/A
- Revenue Next Year
- IPSC N/A
- KOSS N/A
- P/E Ratio
- IPSC N/A
- KOSS N/A
- Revenue Growth
- IPSC 8286.72
- KOSS N/A
- 52 Week Low
- IPSC $0.34
- KOSS $3.81
- 52 Week High
- IPSC $3.29
- KOSS $18.73
- Technical
- Relative Strength Index (RSI)
- IPSC 52.16
- KOSS 46.52
- Support Level
- IPSC $0.58
- KOSS $4.63
- Resistance Level
- IPSC $0.66
- KOSS $6.16
- Average True Range (ATR)
- IPSC 0.04
- KOSS 0.39
- MACD
- IPSC -0.00
- KOSS -0.13
- Stochastic Oscillator
- IPSC 41.52
- KOSS 33.33
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.